HFS
KNSA icon

Hughes Financial Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Hughes Financial Services’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24
Closed -$522 – 1149
2025
Q1 		$522 Buy
+24
New +$494 ﹤0.01% 875

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Hughes Financial Services's KNSA Position: Q2 2025 in Review

Hughes Financial Services sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2025, closing a stake of 24 shares — an estimated $522 sold.

Hughes Financial Services first reported a position in KNSA in Q1 2025 and held it in 1 quarter. The position peaked at $522 in Q1 2025. 189 funds tracked by Wall St. Rank hold KNSA as of Q2 2025.

  • Hughes Financial Services reported no remaining Kiniksa Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Hughes Financial Services sold 24 Kiniksa Pharmaceuticals shares in Q2 2025, an estimated $522.
  • Hughes Financial Services first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Hughes Financial Services's Kiniksa Pharmaceuticals position peaked at $522 in Q1 2025.
  • 189 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2025.

Based on Hughes Financial Services's 13F filing for Q2 2025, filed 7 Aug 2025.